-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
![volition-pet-owners-8](https://volition.com/wp-content/uploads/2023/12/volition-pet-owners-8.jpg)
![volition-pet-owners-8](https://volition.com/wp-content/uploads/2023/12/volition-pet-owners-8.jpg)
Watch our short video, featuring Volition Chief Medical Officer, Heather Wilson-Robles, to learn about the importance of ensuring your canine patients are fasted before you collect samples to run the Nu.Q® Vet Cancer Test.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields